共 13 条
[1]
The effects of a specific neutrophil elastase inhibitor (ONO-5046) in pulmonary ischemia–reperfusion injury[J] . Norihiko Ishikawa,Makoto Oda,Masahiko Kawaguchi,Yoshio Tsunezuka,Go Watanabe.Transplant International . 2003 (5)
[2]
Neutrophil elastase and acute lung injury: Prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics[J] . Bernhardt G. Zeiher,Shozo Matsuoka,Kazuhito Kawabata,John E. Repine.Critical Care Medicine . 2002 (5 Su)
[4]
Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies[J] . Vittorio Dal Piaz,Maria Paola Giovannoni.European Journal of Medicinal Chemistry . 2000 (5)
[5]
Tiotropium (SPIRIVA ? ): Mechanistical considerations and clinical profile in obstructive lung disease[J] . Bernd Disse,Georg A. Speck,Karl Ludwig Rominger,Theodore J. Witek,Rudolf Hammer.Life Sciences . 1999 (6)
[6]
Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?[J] . M.M. Teixeira,R.W. Gristwood,N. Cooper,P.G. Hellewell.Trends in Pharmacological Sciences . 1997 (5)
[7]
Adverse Effects of Corticosteroid Therapy for COPD[J] . Charlene E McEvoy,Dennis E Niewoehner.Chest . 1997 (3)
[8]
Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease[J] . Peter J Barnes,Maria G Belvisi,Judith C.W. Mak,El-Bdaoui Haddad,Brian O’Connor.Life Sciences . 1995 (11)
[9]
long-actingβ2 agonists in the management of stablechronic obstructive pulmonary disease. Cazzola M, Donner CF. Drugs . 2000
[10]
Cilomilast (Ariflo ) 15mg bid safety in a 6-month clinical trial program. Compton CH, Edelson JD, Cedar E, et al. American Journal of Respiratory and Critical Care Medicine . 2001